Commercial Access Only
Specimen SS-COM-AST-0327 // ASTRINGENCY
Grape Extract T2-BL-PH
Vitis vinifera
Grape
Grape Extract SeriesTier 2
Target Trait
400
mg/L
Reported target: 400 mg/L proanthocyanidin
Technical Specifications
Genomic Edits
8
GC Content
(49%)
Construct Length
6,480 bp
Promoter System
CaMV 35S / Ubiquitin
Expression System
Biolistic transformation
Host Strain
Particle Gun
Pathway Edits
- LAR + ANR co-expression
- Proanthocyanidin pathway initiation
Key Interventions
LAR/ANR dual-cassette co-expressionProanthocyanidin B-type dimer initiation
Application Domains
PharmaceuticalResearch
Intended Use
High-purity grape tannin extract for pharmaceutical-grade astringency compounds — Pharmaceutical, Research grade via biolistic transformation.
Access
Request Commercial Access
This construct is available exclusively to qualified institutions. Submit an inquiry to receive technical documentation and licensing terms.
Contact Us →No pricing is listed publicly. We respond to all qualified inquiries within 2 business days.